NEXT GEN PHARMA
Board
1 director, since incorporationDirector
since 02-12-2022
term without a fixed end
listed in the 2025 annual accounts, filed on 07-08-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 06-12-2022
Mandates through the years
1 name, the dashed line is todayDirector
Board
Mandates as a list
-
- Director, from 02-12-2022 to date
Control
share not stated
This company
NEXT GEN PHARMA
Equity €3.2m
Profit €611,794 in 2025
Capital
- Contribution
- €1,374,000
- Shares
- 1,374
- Contribution per share
- €1,000
- Equity per share
- €2,319 in 2025
- Source
- deed of 06-12-2022
Articles of association
deed of 06-12-2022 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Sunday of June at 14:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- Bij ontbinding om welke reden en op welk ogenblik ook, algemene vergadering mag één of meerdere vereffenaars aanduiden,hun bevoegdheden omlijnen en vergoeding b…
Capital transactions
Shareholders according to the deeds
At incorporation
deed of 06-12-2022 ↗
- 1,374 shares (100%) · €1,374,000
Capital over time
- 06-12-2022 Incorporation · €1,374,000 · 1,374 shares